The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
National health care costs of peripheral arterial disease in the Medicare population
Abstract
Abstract Lower extremity peripheral arterial disease (PAD) is prevalent in the Medicare population and is associated with high rates of myocardial infarction, stroke, amputation, and death. Nevertheless, national health expenditures for PAD are not known. We hypothesized that PAD-related costs are high, increase with age, and that treatment rates would be less than known PAD prevalence. The objective was to determine national health care expenditures for PAD in the United States. PAD-related treatment costs were calculated in the elderly, non-disabled Medicare population. The cost analysis relied on the 5% control population for the linked SEER-Medicare data and Medicare claims for the calendar year 2001, identifying PAD cases based on diagnosis and procedure codes. Costs were aggregated separately for inpatient and outpatient treatment and estimates adjusted to reflect the Medicare population. A total of $4.37 billion was spent on PAD-related treatment and 88% of expenditures were for inpatient care. Medicare program outlays totaled $3.87 billion, while enrollees (or their supplemental insurance) spent the remaining $500 million. In total, 6.8% of the elderly Medicare population received treatment for PAD. Treatment increased with age at rates of 4.5%, 7.5%, and 11.8% for individuals aged 65–74, 75–84, and >85 years, respectively. PAD-related costs accounted for approximately 13% of all Medicare Part A and B expenditures for the PAD-treated cohort, and 2.3% of total Medicare Part A and B expenditures. In conclusion, US national PAD-related costs are high, associated with inpatient care, and increase with age. PAD is treated at rates lower than the known PAD prevalence as only approximately one-third of the population with known PAD had detectable PAD-related health care costs in our analysis. The potential impact of earlier PAD detection and use of outpatient preventive strategies on total national PAD health care costs is unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Self-citationWriting Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
Criqui, M. H., Langer, R. D., Fronek, A., Feigelson, H. S., Klauber, M. R., McCann, T. J., & Browner, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260605 · Cited by 2,579
Selvin, E., & Erlinger, T. P. (2004) · Circulation · doi:10.1161/01.cir.0000137913.26087.f0 · Cited by 1,885
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Medical treatment of peripheral arterial disease and claudication
Hiatt, W. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442108 · Cited by 1,121
The prevalence of peripheral arterial disease in a defined population.
Criqui, M. H., Fronek, A., Barrett-Connor, E., Klauber, M. R., Gabriel, S., & Goodman, D. (1985) · Circulation · doi:10.1161/01.cir.71.3.510 · Cited by 1,087
Newman, A. B., Shemanski, L., Manolio, T. A., Cushman, M., Mittelmark, M., Polak, J. F., Powe, N. R., & Siscovick, D. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.538 · Cited by 871
LENG, G. C., LEE, A. J., FOWKERS, F. G. R., WHITEMAN, M., DUNBAR, J., HOUSLEY, E., & RUCKLEY, C. V. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.6.1172 · Cited by 667
Cited by
Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease
Barnes, J. A., Eid, M. A., Creager, M. A., & Goodney, P. P. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314595 · Cited by 516
Nehler, M. R., Duval, S., Diao, L., Annex, B. H., Hiatt, W. R., Rogers, K., Zakharyan, A., & Hirsch, A. T. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.03.290 · Cited by 502
Self-citationMahoney, E. M., Wang, K., Keo, H. H., Duval, S., Smolderen, K. G., Cohen, D. J., Steg, G., Bhatt, D. L., Hirsch, A. T., & on behalf of the Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators* (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.930735 · Cited by 256
Self-citationCritical Limb Ischemia: Current Trends and Future Directions
Teraa, M., Conte, M. S., Moll, F. L., & Verhaar, M. C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002938 · Cited by 256
Gardner, A. W., Parker, D. E., Montgomery, P. S., & Blevins, S. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001107 · Cited by 240
Metadata
- Authors
- Hirsch, A. T., Hartman, L., Town, R. J., & Virnig, B. A.
- Venue
- Vascular Medicine
- Publisher
- SAGE Publications
- Published
- 2008-08
- Volume
- 13
- Issue
- 3
- Pages
- 209-215
- ISSN
- 1358-863X (ISSN-L)
- 1477-0377
- OpenAlex
- W2171923126
- Cited by
- 342
- References
- 30
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National health care costs of peripheral arterial disease in the Medicare population. https://app.cochat.ai/papers/10.1177/1358863x08089277
- The paper
- Hirsch, A. T., Hartman, L., Town, R. J., & Virnig, B. A. (2008). National health care costs of peripheral arterial disease in the Medicare population. Vascular Medicine. https://doi.org/10.1177/1358863x08089277
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.